Search
Search Funnelback University
1 -
10 of
23
search results for lupus |u:www2.mrc-lmb.cam.ac.uk
Fully-matching results
-
A unified evolutionary origin for the ubiquitous protein transporters …
https://www2.mrc-lmb.cam.ac.uk/groups/hegde/wp-content/uploads/sites/8/2023/08/BMC_Biology_2021.pdf15 Dec 2021: a The models are, from left to right and then top to bottom, Canis lupus familiaris SEC61A1 (6fti), Homo sapiensTMCO1 (6w6l), H. -
bst641-09a
https://www2.mrc-lmb.cam.ac.uk/groups/rlw/download/publications/19614567.pdf2 Aug 2010: Morton. Lecture. Morton LectureForm and flexibility in phosphoinositide 3-kinasesRoger Williams1, Alex Berndt, Simon Miller, Wai-Ching Hon and Xuxiao ZhangMRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 0QH, U.K. AbstractPI3Ks -
Human Antibodies developed for Treatment of Lupus and Anthrax - MRC…
https://www2.mrc-lmb.cam.ac.uk/human-antibodies-developed-for-treatment-of-lupus-and-anthrax/31 Jul 2009: If approved, belimumab would become the first new drug treatment for lupus in 50 years. ... Elevated levels of B-lymphocyte stimulator have been associated with autoantibodies in lupus and certain other autoimmune diseases. -
Human antibody approved for treatment of lupus - MRC Laboratory of…
https://www2.mrc-lmb.cam.ac.uk/human-antibody-approved-for-treatment-of-lupus/11 Mar 2011: Search this website. Human antibody approved for treatment of lupus. Human antibody approved for treatment of lupus. ... Benlysta was approved for use against lupus on 10 March 2011 by the U.S. -
Insights into how KAP1 silences viral origin DNA in our genomes - MRC …
https://www2.mrc-lmb.cam.ac.uk/insights-into-how-kap1-silences-viral-origin-dna-in-our-genomes/10 Jul 2019: geographic atrophy, and lupus. -
New drug Benlysta in Lupus treatment - MRC Laboratory of Molecular…
https://www2.mrc-lmb.cam.ac.uk/new-drug-benlysta-in-lupus-treatment/15 Jun 2011: Search this website. New drug Benlysta in Lupus treatment. New drug Benlysta in Lupus treatment. ... Published on. 15 June, 2011. “Benlysta emerges as a direct approach in lupus treatment. -
LMB In The News - Page 73 of 87 - MRC Laboratory of Molecular Biology
https://www2.mrc-lmb.cam.ac.uk/news-events/lmb-in-the-news/page/73/New drug Benlysta in Lupus treatment. ... Published on. 15 June, 2011. “Benlysta emerges as a direct approach in lupus treatment. -
LMB News - Page 77 of 81 - MRC Laboratory of Molecular Biology
https://www2.mrc-lmb.cam.ac.uk/news-events/lmb-news/page/77/for treatment of lupus. ... Published on. 11 March, 2011. Systemic lupus erythematosus is a chronic, life-threatening inflammatory autoimmune disease that can cause debilitating fatigue, painful and swollen joints, fever, skin rash, and kidney problems. -
LMB News - Page 81 of 81 - MRC Laboratory of Molecular Biology
https://www2.mrc-lmb.cam.ac.uk/news-events/lmb-news/page/81/Yonath (Weizmann Institute of Science, Israel). The trio showed how the information encoded on strands of DNA […]. Human Antibodies developed for Treatment of Lupus and Anthrax. ... treat lupus, a potentially fatal autoimmune disease, and anthrax, a -
History Of Technology Transfer - MRC Laboratory of Molecular Biology
https://www2.mrc-lmb.cam.ac.uk/research/technology-transfer/history-of-technology-transfer/21 Jul 2023: Other antibodies followed, including BENLYSTA, which promises to be the first new drug treatment for systemic lupus erythematosus (SLE) in 50 years and Abthrax, against infectious anthrax, which has been stockpiled
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
- katalk:za33 24 |u:www.computeroffice.law.cam.ac.uk (0) · moments ago
- tj KaKaotalk:PC53 |u:www2.mrc-lmb.cam.ac.uk (53) · moments ago
Recent searches
Your search history is empty.